Efficacy and safety of itolizumab, a novel anti-CD6 monoclonal antibody, in patients with moderate to severe chronic plaque psoriasis: results of a double-blind, randomized, placebo-controlled, phase-III study

Autor: Vijay Garg, M. S. Ramakrishnan, Pradip Nair, Enrique Montero, G. Manmohan, Mahendra M Kura, Abir Saraswat, Dasiga Venkata Subrahmanya Pratap, Prasanna C. Ganapathi, Sunil Dogra, Neeraj Pandey, Narendra J Shetty, C.R. Srinivas, T.K. Sumathy, Ramesh M Bhat, Kotla Sai Krishna, Radha Shah, M.G. Gopal, Dalavoi Padmaja, Uday Khopkar, D.S. Krupashankar, Leelavathy Budamakuntla, T Narayana Rao, Sandesh Gupta

Publikováno v: Journal of the American Academy of Dermatology. 71(3)

Background Itolizumab, a humanized monoclonal antibody to CD6, is a novel therapeutic agent evaluated in chronic plaque psoriasis. Objective We sought to assess the safety and efficacy of itolizumab in moderate to severe chronic plaque psoriasis. Met

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3cdaad2e1efe6892ade9d79c1400bb12
https://pubmed.ncbi.nlm.nih.gov/24703722

Therapeutic Inertia in the Management of Psoriasis: A Quantitative Survey Among Indian Dermatologists and Patients.

Autor: Rajagopalan M; Department of Dermatology, Apollo Hospital, Chennai, India., Dogra S; Department of Dermatology Venereology & Leprology Postgraduate Institute of Medical Education & Research (PGIMER), Chandigarh, 160012, India., Godse K; DY Patil University School of Medicine, Navi Mumbai, India., Kar BR; Department of Dermatology, IMS and SUM Hospital, Bhubaneshwar, Odisha, India., Kotla SK; Department of Dermatology, Yashodha Hospital, Secunderabad, India., Neema S; Department of Dermatology, Armed Forces Medical College, Pune, Maharashtra, India., Saraswat A; Indushree Skin Clinic, Lucknow, India., Shah SD; Department of Dermatology, Ashwini Rural Medical College, Solapur, India., Madnani N; Hinduja Hospital, Mumbai, India.; Sir. H. N. Reliance Hospital, Mumbai, India., Sardesai V; Bharati Vidyapeeth Medical College, Pune, India., Sekhri R; Fortis Hospital, Noida, India., Varma S; Skinvita Clinic, Kolkata, West Bengal, India., Arora S; Army College of Medical Sciences, New Delhi, India., Kawatra P; Novartis, Mumbai, India.

Publikováno v: Psoriasis (Auckland, N.Z.) [Psoriasis (Auckl)] 2022 Aug 25; Vol. 12, pp. 221-230. Date of Electronic Publication: 2022 Aug 25 (Print Publication: 2022).